Inequalities in the provisions of disease modifying therapies for multiple sclerosis in the UK

被引：0
|
作者：
Evangelou, N.
Karsay, A.
Owens, T.
机构：
[1] Univ Nottingham, Dept Neurol, Queens Med Ctr, Nottingham NG7 2RD, England
[2] Univ Nottingham, Dept Econ, Nottingham NG7 2RD, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2006年 / 77卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
058
引用
收藏
页码：1399 / 1399
页数：1
相关论文
共 50 条
  • [31] Benign multiple sclerosis in the era of disease modifying therapies
    Diaz-Cruz, Camilo
    Gonzalez, Cindy
    Chua, Alicia
    Healy, Brian
    Sattarnezhad, Neda
    Stankiewicz, James
    Severson, Christopher
    Bhattacharyya, Shamik
    Kimbrough, Dorian
    Glanz, Bonnie
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [32] Access and use of clinical services and disease modifying therapies by people with progressive multiple sclerosis in the UK
    Campbell, E.
    Coulter, E.
    Mattison, P. G.
    Miller, L.
    McFadyen, A.
    Paul, L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 369 - 370
  • [33] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
  • [34] Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
    Bross, Madeline
    Hackett, Melody
    Bernitsas, Evanthia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 15
  • [35] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [36] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [37] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Hartung, Daniel M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [38] Comparison of dropout rates of disease modifying therapies in multiple sclerosis
    Kurtuncu, M.
    Celik, S. Yildiz
    Coban, A.
    Shugaiv, E.
    Pehlivan, M.
    Akman-Demir, G.
    Eraksoy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 198 - 198
  • [39] Regulation of human glia by multiple sclerosis disease modifying therapies
    Healy, Luke M.
    Michell-Robinson, Mackenzie A.
    Antel, Jack P.
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (06) : 639 - 649
  • [40] Comparing the efficacy of disease-modifying therapies in multiple sclerosis
    Mitsikostas, Dimos D.
    Goodin, Douglas S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 109 - 116
12345